FDA Recalls Betamethasone Injection Due to Sterility Assurance Concerns
FVS Holdings, Inc. dba. Green Valley Drugs is recalling Betamethasone Combination with Lidocaine and Bupivacaine Injection due to lack of assurance of sterility.
What this means for you
Illness, injury, or structural failure has been reported. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: The recall is classified as FDA Class II. According to the rubric, an FDA Class II recall involving a sterile product with sterility assurance concerns is categorized as Severe (Score 4) due to the potential for significant injury from infection.
Plain-English summary
FVS Holdings, Inc. dba. Green Valley Drugs is recalling Betamethasone Combination with Lidocaine 1% and Bupivacaine 0.5 % Injection. The recall covers all strengths and presentations, including Betameth combo 6 mg/mL lido 1% bup 0.5% syr and Betameth Combo/Lidocaine 1%/ Bupivacaine 0.5% Syr. The product is prescription-only and was distributed nationwide.
The recall is being conducted due to a lack of assurance of sterility for all sterile products compounded, repackaged, and distributed by the pharmacy. This decision follows concerns associated with the facility's quality control processes.
Patients who have received this medication should contact their healthcare provider for further instructions. The specific lot numbers and expiration dates are listed in the structured product information.
The recalled product
- Product
- Betamethasone Combination with Lidocaine 1% and Bupivacaine 0.5 % Injection, all strengths and all presentations including a) Betameth combo 6 mg/mL lido 1% bup 0.5% syr; and b) Betameth Combo/Lidocaine 1%/ Bupivacaine 0.5% Syr, Rx only, Green Valley Drugs, 1850 Whitney Mesa, #18
- Manufacturer
- FVS Holdings, Inc. dba. Green Valley Drugs
- Affected units
- 270
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (6)
- Lot #: a) Betameth combo 6mg/ml lido1% bup 0.5% syr: 13021975
- Exp 5/19/2013
- b) Betameth Combo/Lidocaine 1%/ Bupivacaine 0.5% Syr: 13012550
- Exp 4/25/2013
- 130215100
- Exp 5/15/2013
Distribution
Distributed nationwide across the United States.
Part of a larger recall action
This product is one of 78 recalled by FVS Holdings, Inc. dba. Green Valley Drugs under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 78 products in this recall →Related recalls
Same manufacturer · FVS Holdings, Inc. dba. Green Valley Drugs
See all →- SevereGreen Valley Drugs Recalls Alpha Lipoic Acid Injection Due to Sterility Concerns
FDA (Drugs) · 2013-05-22
- SevereGreen Valley Drugs Recalls Phosphatidylcholine Injection Due to Sterility Concerns
FDA (Drugs) · 2013-05-22
- SevereFDA Recalls Acetylcysteine Injection Due to Sterility Assurance Concerns
FDA (Drugs) · 2013-05-22
- SevereGreen Valley Drugs Recalls Thiamine Hydrochloride Injection Due to Sterility Concerns
FDA (Drugs) · 2013-05-22
- SevereGreen Valley Drugs Recalls Folic Acid Injections Due to Sterility Concerns
FDA (Drugs) · 2013-05-22
Same hazard · sterility
See all →- SevereRegeneron Recalls Libtayo Injection Due to Sterility Assurance Concerns
FDA (Drugs) · 2026-08-26
- SeverePrestige Recalls Clear Eyes Maximum Itchy Eye Relief Due to Sterility Concerns
FDA (Drugs) · 2026-08-19
- SevereROHTO Cooling Eye Drops Recalled Over Sterility Assurance Concerns
FDA (Drugs) · 2026-07-29
- HighROHTO Cooling Eye Drops Recalled Over Sterility Assurance Concerns
FDA (Drugs) · 2026-07-29
- SevereFDA Recalls ROHTO OPTIC GLOW Eye Drops Over Sterility Concerns
FDA (Drugs) · 2026-07-29